Results 161 to 170 of about 3,038,457 (311)

Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy

open access: yesMolecular Oncology, EarlyView.
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley   +1 more source

Intergovernmental Panel on Climate Change, 13th Session, Maldives, 22 & 25-28 September 1997

open access: yes, 1997
The Panel approved various draft reports including the draft report of the 12th session. The Panel noted the draft decision paper (introduced by Dr. Watson) on the TAR, and after extensive discussions and amendments, the panel approved the decision ...
World Metrological Organization (WMO)   +2 more
core  

Spatial heterogeneity of hotspot mutations and clonal relatedness in ovarian endometrioid carcinoma

open access: yesMolecular Oncology, EarlyView.
Spatially resolved analysis revealed heterogeneous distributions of selected cancer‐associated mutations within ovarian endometrioid carcinomas. Shared mutations between paired endometrial and ovarian tumors supported clonal relatedness. These findings highlight the value of sampling multiple tumor regions when interpreting molecular profiles ...
Takahito Ashihara   +10 more
wiley   +1 more source

PANEL DISCUSSION: PATHOPHYSIOLOGY AND IMMUNOLOGY

open access: yes, 2017
PANEL ...
Discussion, Panel
core  

Panel Discussions [PDF]

open access: yesPostgraduate Medical Journal, 1955
openaire   +2 more sources

Correction: SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma. [PDF]

open access: yesJ Exp Med
Portelinha A   +18 more
europepmc   +1 more source

Q & A Panel

open access: yes, 2011
Medicine & Science Panel Discussion, October 26 2011, 5:30pmMedicine & Science Panel Discussion, October 26 2011, 5 ...
Knight, John
core  

Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer

open access: yesMolecular Oncology, EarlyView.
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy